Biogen Message Board - Msg: 322946

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 176.01

-0.2%

Dec 31 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rick Lundberg who wrote (32)	10/3/1996 7:42:00 AM
From: Harold Engstrom	of 1686

Rick, the site looks good, much better presentation than anywhere else. The news about new MS drugs that are being tested is great for sufferers and wouldn't seem to affect Biogen for some time. Still, the one thing that is missing from all corporate profiles and public statements is a path forward towards more products. The few that seem headed for late-stage trials seem to pale next to Avonex. There have been repeated references to acquistions and additional research directions. Do you have anything that you can tell us in addition to what is published in broad corporate statements? I have a huge amount of faith in Biogen, and am very curious what kind of decisions are in the offing. Thanks for everything, Harold Engstrom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next